436 related articles for article (PubMed ID: 10676638)
1. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.
Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A
Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638
[TBL] [Abstract][Full Text] [Related]
2. Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism.
Luo Y; Rockow-Magnone SK; Kroeger PE; Frost L; Chen Z; Han EK; Ng SC; Simmer RL; Giranda VL
Neoplasia; 2001; 3(5):411-9. PubMed ID: 11687952
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
Hapke G; Yin MB; Wu J; Frank C; Rustum YM
Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
[TBL] [Abstract][Full Text] [Related]
4. A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.
Eastman A; Kohn EA; Brown MK; Rathman J; Livingstone M; Blank DH; Gribble GW
Mol Cancer Ther; 2002 Oct; 1(12):1067-78. PubMed ID: 12481430
[TBL] [Abstract][Full Text] [Related]
5. Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1.
den Elzen NR; O'Connell MJ
EMBO J; 2004 Feb; 23(4):908-18. PubMed ID: 14765108
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
7. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Saccharomyces cerevisiae homologue of Schizosaccharomyces pombe Chk1 involved in DNA-damage-induced M-phase arrest.
Liu Y; Vidanes G; Lin YC; Mori S; Siede W
Mol Gen Genet; 2000 Jan; 262(6):1132-46. PubMed ID: 10660074
[TBL] [Abstract][Full Text] [Related]
9. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation.
O'Connell MJ; Raleigh JM; Verkade HM; Nurse P
EMBO J; 1997 Feb; 16(3):545-54. PubMed ID: 9034337
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224
[TBL] [Abstract][Full Text] [Related]
11. The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast.
Wan S; Capasso H; Walworth NC
Yeast; 1999 Jul; 15(10A):821-8. PubMed ID: 10407262
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis.
Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS
Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.
Tian H; Faje AT; Lee SL; Jorgensen TJ
Neoplasia; 2002; 4(2):171-80. PubMed ID: 11896572
[TBL] [Abstract][Full Text] [Related]
14. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.
Sanchez Y; Wong C; Thoma RS; Richman R; Wu Z; Piwnica-Worms H; Elledge SJ
Science; 1997 Sep; 277(5331):1497-501. PubMed ID: 9278511
[TBL] [Abstract][Full Text] [Related]
15. Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.
Furnari B; Rhind N; Russell P
Science; 1997 Sep; 277(5331):1495-7. PubMed ID: 9278510
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
17. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.
Graves PR; Yu L; Schwarz JK; Gales J; Sausville EA; O'Connor PM; Piwnica-Worms H
J Biol Chem; 2000 Feb; 275(8):5600-5. PubMed ID: 10681541
[TBL] [Abstract][Full Text] [Related]
18. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.
Rhind N; Furnari B; Russell P
Genes Dev; 1997 Feb; 11(4):504-11. PubMed ID: 9042863
[TBL] [Abstract][Full Text] [Related]
19. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
Yin M; Hapke G; Guo B; Azrak RG; Frank C; Rustum YM
Oncogene; 2001 Aug; 20(38):5249-57. PubMed ID: 11536038
[TBL] [Abstract][Full Text] [Related]
20. Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
Jiang X; Wang J; Xing L; Shen H; Lian W; Yi L; Zhang D; Yang H; Liu J; Zhang X
Arch Toxicol; 2017 Jan; 91(1):259-270. PubMed ID: 26914363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
